Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis – epidemiology, risk factors, clinical implications and treatment

In recent years, rapid growth of incidence of metabolic syndrome, obesity and diabetes has been noted worldwide. Concurrent non-alcoholic steatohepatitis (NASH) has become a dominant factor of hepatic cirrhosis and hepatocellular carcinoma (HCC). The most important risk factors of transition from NA...

Descripción completa

Detalles Bibliográficos
Autores principales: Straś, Wojciech, Małkowski, Piotr, Tronina, Olga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2020
Materias:
Review Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592090/
https://www.ncbi.nlm.nih.gov/pubmed/33145423
http://dx.doi.org/10.5114/ceh.2020.99506

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592090/
https://www.ncbi.nlm.nih.gov/pubmed/33145423
http://dx.doi.org/10.5114/ceh.2020.99506

Ejemplares similares